CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 460 enrolled
Drug / intervention
MRI +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03495115
NCT03495115N/ACompleted

Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening

Beth Israel Deaconess Medical Center·interventional·Posted Apr 11, 2018·Updated Apr 17, 2026

In Brief

A clinical study evaluating MRI and RSI for Breast Cancer. Completed, enrolled 460 participants across 1 site.

Detailed Summary

This study is looking at a breast cancer screening technique, restriction spectrum imaging (RSI), as a possible alternative to the breast Magnetic Resonance Imaging (MRI) used by most healthcare professionals. The technique involved in this study is: -Restriction Spectrum Imaging (RSI)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 11, 2018
Enrollment StartApr 18, 2018
Primary CompletionDec 30, 2023
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 8.2 years ago

Interventions

MRIdevice

A MRI uses a strong magnet to produce detailed pictures of the inside of your body.

RSIdevice

RSI is a technique that aims to improve the pictures produced during a MRI exam.